Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

DiaNat-DB: a molecular database of antidiabetic compounds from medicinal plants
Abraham Madariaga‐Mazón, J. Jesús Naveja, José L. Medina‐Franco, et al.
RSC Advances (2021) Vol. 11, Iss. 9, pp. 5172-5178
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

The LOTUS initiative for open knowledge management in natural products research
Adriano Rutz, Maria Sorokina, Jakub Galgonek, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 231
Freshwater fungal biology
Mark S. Calabon, KD Hyde, Ebg Jones, et al.
Mycosphere (2023) Vol. 14, Iss. 1, pp. 195-413
Open Access | Times Cited: 29
Natural products targeting inflammation-related metabolic disorders: A comprehensive review
Firzan Nainu, Andri Frediansyah, Sukamto S. Mamada, et al.
Heliyon (2023) Vol. 9, Iss. 6, pp. e16919-e16919
Open Access | Times Cited: 21
The LOTUS Initiative for Open Natural Products Research: Knowledge Management through Wikidata
Adriano Rutz, Maria Sorokina, Jakub Galgonek, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 35
Novel molecular hybrids of EGCG and quinoxaline: Potent multi-targeting antidiabetic agents that inhibit α-glucosidase, α-amylase, and oxidative stress
Manan Kothari, K. K. Kannan, Revathy Sahadevan, et al.
International Journal of Biological Macromolecules (2024) Vol. 263, pp. 130175-130175
Closed Access | Times Cited: 5
Approaches for enhancing the analysis of chemical space for drug discovery
Fernanda I. Saldívar‐González, José L. Medina‐Franco
Expert Opinion on Drug Discovery (2022) Vol. 17, Iss. 7, pp. 789-798
Open Access | Times Cited: 21
Potential use of the Asteraceae family as a cure for diabetes: A review of ethnopharmacology to modern day drug and nutraceuticals developments
Yugal Kishore Mohanta, Awdhesh Kumar Mishra, Amilia Nongbet, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 11
Timbe (Acaciella angustissima) as an Alternative Source of Compounds with Biological Activity: Antidiabetic
Diana Karina Rangel-Sandoval, Lucia Guerrero-Becerra, Consuelo Lomas‐Soria, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 593-593
Open Access
Chemoinformatic Characterization of Synthetic Screening Libraries Focused on Epigenetic Targets
E. Alexis Flores‐Padilla, K. Eurídice Juárez‐Mercado, J. Jesús Naveja, et al.
Molecular Informatics (2021) Vol. 41, Iss. 6
Open Access | Times Cited: 25
In silico design and pharmacokinetics investigation of some novel hepatitis C virus NS5B inhibitors: pharmacoinformatics approach
Stephen Ejeh, Adamu Uzairu, Gideon Adamu Shallangwa, et al.
Bulletin of the National Research Centre/Bulletin of the National Research Center (2022) Vol. 46, Iss. 1
Open Access | Times Cited: 17
Advanced Bioinformatics Tools in the Pharmacokinetic Profiles of Natural and Synthetic Compounds with Anti-Diabetic Activity
Ana-Maria Udrea, Graţiela Grădişteanu Pîrcălăbioru, Anca Andreea Boboc, et al.
Biomolecules (2021) Vol. 11, Iss. 11, pp. 1692-1692
Open Access | Times Cited: 21
Cheminformatics study of some indole compounds through QSAR modeling, ADME prediction, molecular docking, and molecular dynamic simulation to identify novel inhibitors of HCV NS5B protease
Stephen Ejeh, Adamu Uzairu, Gideon Adamu Shallangwa, et al.
Journal of the Indian Chemical Society (2023) Vol. 100, Iss. 3, pp. 100955-100955
Closed Access | Times Cited: 8
In Silico Searching for Alternative Lead Compounds to Treat Type 2 Diabetes through a QSAR and Molecular Dynamics Study
N. Cabrera, Sebastián A. Cuesta, José R. Mora, et al.
Pharmaceutics (2022) Vol. 14, Iss. 2, pp. 232-232
Open Access | Times Cited: 13
Traditional Medicinal Plants as a Source of Inspiration for Osteosarcoma Therapy
Liliya Kazantseva, José Becerra, Leonor Santos‐Ruiz
Molecules (2022) Vol. 27, Iss. 15, pp. 5008-5008
Open Access | Times Cited: 12
Visualization, Exploration, and Screening of Chemical Space in Drug Discovery
J. Jesús Naveja, Fernanda I. Saldívar‐González, Diana L. Prado‐Romero, et al.
(2024), pp. 365-393
Closed Access | Times Cited: 2
Automatic Identification of Analogue Series from Large Compound Data Sets: Methods and Applications
J. Jesús Naveja, Martin Vogt
Molecules (2021) Vol. 26, Iss. 17, pp. 5291-5291
Open Access | Times Cited: 13
Design of a multi-target focused library for antidiabetic targets using a comprehensive set of chemical transformation rules
Fernanda I. Saldívar‐González, Gabriel Navarrete‐Vázquez, José L. Medina‐Franco
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 5
In silico screening, pharmacokinetic, DFT, and dynamics simulation study of ant-hepatitis C virus compounds as potential NS5B Polymerase inhibitors
Stephen Ejeh, Adamu Uzairu, Gideon Adamu Shallangwa, et al.
Scientific African (2024) Vol. 23, pp. e02102-e02102
Open Access | Times Cited: 1
Computational approaches for lead compound discovery in dipeptidyl peptidase-4 inhibition using machine learning and molecular dynamics techniques
Sandra De La Torre, Sebastián A. Cuesta, Luis Calle, et al.
Computational Biology and Chemistry (2024) Vol. 112, pp. 108145-108145
Closed Access | Times Cited: 1
Molecular approaches for extraction and screening of bioactive compounds from forest fungi
Ozioma Forstinus Nwabor, Helen Onyeaka, Ogueri Nwaiwu
Elsevier eBooks (2024), pp. 125-145
Closed Access | Times Cited: 1
Structure-based design, drug-likeness, and pharmacokinetic studies of novel substituted pyrimidine derivatives as potent HCV NS3/A4 protease inhibitors
Stephen Ejeh, Adamu Uzairu, Gideon Adamu Shallangwa, et al.
Biocatalysis and Agricultural Biotechnology (2022) Vol. 46, pp. 102539-102539
Closed Access | Times Cited: 7
In-silico profiling, design, molecular docking computation, and drug kinetic model evaluation of novel curcumin derivatives as potential anticancer agents
Anne Jibrin, Adamu Uzairu, Gideon Adamu Shallangwa, et al.
Journal of the Indian Chemical Society (2023) Vol. 100, Iss. 4, pp. 100979-100979
Closed Access | Times Cited: 3
Chemo-structural diversity of anti-obesity compound database
Lavanya Prabhakar, Dicky John Davis G
Journal of Molecular Graphics and Modelling (2023) Vol. 120, pp. 108414-108414
Closed Access | Times Cited: 2
In silico screening of potential Tumor necrosis factor alpha (TNF-α) inhibitors through molecular modeling, molecular docking, and pharmacokinetics evaluations
Stephen Eyije Abechi, Stephen Ejeh, Abduljelil Ajala
Scientific African (2023) Vol. 21, pp. e01830-e01830
Open Access | Times Cited: 2
Assessment of the Antidiabetic Properties of Essential Oil from Cannabis sativa
Saima Naz, Ali Raza Kashif, Abdul Tawab, et al.
Journal Advances of Nutrition Science and Technology (2023) Vol. 3, Iss. 3-4, pp. 78-86
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top